Ditchcarbon
  • Customers
  1. Organizations
  2. Abbott
Public Profile
Medical Device Manufacturing
US
updated 2 days ago

Abbott

Company website

Abbott Laboratories, commonly known as Abbott, is a leading global healthcare company headquartered in the United States. Founded in 1888, Abbott has established a strong presence in various operational regions, including North America, Europe, and Asia. The company operates primarily in the medical devices, diagnostics, nutrition, and pharmaceuticals sectors. Abbott is renowned for its innovative products, such as the FreeStyle Libre glucose monitoring system and Similac infant formula, which set industry standards for quality and effectiveness. With a commitment to advancing health and well-being, Abbott has achieved significant milestones, including the rapid development of COVID-19 testing solutions. As a market leader, Abbott consistently ranks among the top healthcare companies worldwide, recognised for its dedication to research and development, and its ability to deliver cutting-edge solutions that improve patient outcomes.

DitchCarbon Score

How does Abbott's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

62

Industry Average

Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

26

Industry Benchmark

Abbott's score of 62 is higher than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.

80%

Let us know if this data was useful to you

Abbott's reported carbon emissions

In 2023, Abbott Laboratories reported significant carbon emissions across various regions, with total emissions in the US reaching approximately 411,000,000 kg CO2e, comprising about 207,000,000 kg CO2e from Scope 1 and about 204,000,000 kg CO2e from Scope 2. In the UK, total emissions were about 10,368,000 kg CO2e, with Scope 1 emissions at approximately 499,000 kg CO2e, Scope 2 emissions at about 8,000,000 kg CO2e, and Scope 3 emissions contributing approximately 9,543,000 kg CO2e. Abbott has set ambitious targets to reduce its carbon footprint, committing to a 30% reduction in absolute Scope 1 and 2 emissions by 2030, using 2018 as the baseline year. This commitment aligns with the Science Based Targets initiative (SBTi) and aims to keep global warming well below 2°C. The company also aims for 82% of its suppliers, by emissions, to have science-based targets by 2026. In addition to these near-term goals, Abbott Laboratories has pledged to achieve net-zero emissions by 2050, demonstrating a long-term commitment to sustainability and climate action. The initiatives include operational energy efficiency, purchasing renewable energy, and integrating sustainable engineering technologies into projects. Overall, Abbott's climate commitments reflect a proactive approach to reducing greenhouse gas emissions and addressing climate change, with a clear focus on both immediate and long-term sustainability goals.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

201020132014201520162017201820192020202120222023
Scope 1
620,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
0,000,000
0,000,000
Scope 2
648,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 3
-
-
-
-
-
000,000,000
-
-
-
-
0,000,000,000
0,000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Abbott's primary industry is Medical, precision and optical instruments, watches and clocks (33), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Abbott is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Abbott is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Air France Klm

FR
•
Air transport services (62)
Updated 2 days ago

Unilever

GB
•
Food products nec
Updated 2 days ago

Mindray

CN
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 2 days ago

Danone

FR
•
Dairy products
Updated 2 days ago

Johnson And Johnson

US
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Glaxosmithkline

GB
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
dev
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy